Crossmark

Baseline thrombopoietin level is associated with platelet count improvement in thrombocytopenic chronic hepatitis C patients after successful direct-acting antiviral agent therapy

Crossref DOI link: https://doi.org/10.1186/s12876-021-01606-x

Published Online: 2021-01-21

Published Print: 2021-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Chen, Yen-Chun

Ko, Ping-Hung

Lee, Chi-Che

Tseng, Chih-Wei

Tseng, Kuo-Chih http://orcid.org/0000-0002-4811-3018
Funding

Funding for this research was provided by:

Dalin Tzu Chi Hospital (DTCRD108-I-05)
License Information

Text and Data Mining valid from 2021-01-21

Version of Record valid from 2021-01-21
More Information

Article History

Received: 5 September 2020

Accepted: 12 January 2021

First Online: 21 January 2021

Ethics approval and consent to participate

: The study protocol was approved by the Ethics Committee of Dalin Tzu Chi Hospital (approval number B10704013). All patients signed the informed consent.

: Not applicable.

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below